Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-07

Clinical Trial Update: Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating safety and efficacy of ARNI after LVAD implantation in patients with Stage D heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARNI

Snippet

Sponsor: The Cleveland Clinic | Conditions: Stage D Heart Failure | Phase 4 | Status: RECRUITING